טוען...
Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
Succinate dehydrogenase (SDH) mutations lead to the accumulation of succinate, which acts as an oncometabolite. Germline SDHx mutations predispose to paraganglioma (PGL) and pheochromocytoma (PCC), as well as to renal cell carcinoma and gastro‐intestinal stromal tumors. The SDHx genes were the first...
שמור ב:
| הוצא לאור ב: | Clin Genet |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Blackwell Publishing Ltd
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6972524/ https://ncbi.nlm.nih.gov/pubmed/30977114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cge.13553 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|